ImmuCell Profit Margin 2006-2019 | ICCC

Current and historical gross margin, operating margin and net profit margin for ImmuCell (ICCC) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. ImmuCell net profit margin as of September 30, 2019 is -15.64%.
ImmuCell Annual Profit Margins
ImmuCell Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.038B $0.011B
ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $152.034B 27.73
Medtronic (MDT) Ireland $150.632B 20.81
Stryker (SYK) United States $74.735B 25.13
Boston Scientific (BSX) United States $62.262B 29.39
Baxter (BAX) United States $42.637B 25.85
Essilor Luxottica (ESLOY) France $33.791B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.320B 19.02
Terumo (TRUMY) Japan $26.378B 32.92
Lonza Group Ag (LZAGY) Switzerland $25.349B 0.00
Coloplast (CLPBY) Denmark $25.034B 38.63
ResMed (RMD) United States $21.891B 40.38
Smith & Nephew SNATS (SNN) United Kingdom $19.633B 0.00
Sunny Optical Technology (SNPTF) China $19.217B 0.00
Bio-Rad Laboratories (BIO) United States $10.857B 52.11
Insulet (PODD) United States $10.712B 509.65
William Demant Holdings (WILYY) Denmark $7.626B 0.00
DiaSorin S.p.A (DSRLF) Italy $7.616B 0.00
Perrigo (PRGO) Ireland $7.422B 13.84
Canopy Growth (CGC) Canada $7.365B 0.00
Hill-Rom Holdings (HRC) United States $7.342B 21.65
Haemonetics (HAE) United States $5.938B 40.13
Shandong Weigao Medical Polymer (SHWGF) China $5.472B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.844B 30.27
ICU Medical (ICUI) United States $3.765B 24.54
Neogen (NEOG) United States $3.625B 60.65
GW Pharmaceuticals (GWPH) United Kingdom $3.265B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.174B 0.00
Quidel (QDEL) United States $2.995B 28.42
Aurora Cannabis (ACB) Canada $2.833B 0.00
Agios Pharmaceuticals (AGIO) United States $2.691B 0.00
National Vision Holdings (EYE) United States $2.513B 56.71
Cardiovascular Systems (CSII) United States $1.557B 0.00
Aphria (APHA) $1.326B 0.00
InMode (INMD) Israel $1.245B 0.00
AtriCure (ATRC) United States $1.217B 0.00
VAREX IMAGING (VREX) United States $1.208B 24.20
Phibro Animal Health (PAHC) United States $0.994B 18.61
TG Therapeutics (TGTX) United States $0.935B 0.00
NanoString Technologies (NSTG) United States $0.916B 0.00
Lantheus Holdings (LNTH) United States $0.810B 20.23
Eagle Pharmaceuticals (EGRX) United States $0.809B 30.96
LeMaitre Vascular (LMAT) United States $0.707B 39.75
Quanterix (QTRX) United States $0.698B 0.00
PetIQ (PETQ) United States $0.694B 16.94
Omeros (OMER) United States $0.657B 0.00
HEXO (HEXO) $0.573B 0.00
Cerus (CERS) United States $0.566B 0.00
Surmodics (SRDX) United States $0.549B 57.11
MacroGenics (MGNX) United States $0.505B 0.00
OraSure Technologies (OSUR) United States $0.491B 29.48
Meridian Bioscience (VIVO) United States $0.418B 14.38
Organigram Holdings (OGI) Canada $0.401B 0.00
Utah Medical Products (UTMD) United States $0.395B 28.63
Owens & Minor (OMI) United States $0.387B 14.30
BioLife Solutions (BLFS) United States $0.317B 129.08
Zynex (ZYXI) United States $0.283B 32.04
Neptune Wellness Solutions (NEPT) Canada $0.281B 0.00
Bovie Medical (APYX) United States $0.275B 0.00
United Health Products (UEEC) United States $0.254B 0.00
Vapotherm (VAPO) United States $0.245B 0.00
Viemed Healthcare (VMD) United States $0.239B 25.14
Repro-Med Systems (KRMD) United States $0.234B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.170B 0.00
Liberty Health Sciences (LHSIF) Canada $0.170B 0.00
InfuSystems Holdings (INFU) United States $0.164B 824.00
Female Health (VERU) United States $0.156B 0.00
Rockwell Medical (RMTI) United States $0.145B 0.00
MTech Acquisition (KERN) United States $0.136B 0.00
Fonar (FONR) United States $0.131B 9.20
Cytosorbents (CTSO) United States $0.130B 0.00
Chimerix (CMRX) United States $0.118B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 0.00
United-Guardian (UG) United States $0.091B 23.03
Chembio Diagnostics (CEMI) United States $0.078B 0.00
Nephros (NEPH) United States $0.067B 0.00
MRI Interventions (MRIC) United States $0.062B 0.00
Surface Oncology (SURF) United States $0.050B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.015B 0.00
GUARDION HEALTH (GHSI) United States $0.014B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Myomo (MYO) United States $0.008B 0.00
Capricor Therapeutics (CAPR) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00